News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
322,504 Results
Type
Article (17410)
Company Profile (107)
Press Release (304987)
Multimedia
Podcasts (52)
Webinars (10)
Section
Business (109396)
Career Advice (753)
Deals (19308)
Drug Delivery (74)
Drug Development (41174)
Employer Resources (67)
FDA (7092)
Job Trends (7275)
News (180693)
Policy (16277)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (641)
Accelerated approval (2)
Adcomms (6)
Allergies (35)
Alliances (25852)
ALS (42)
Alzheimer's disease (477)
Antibody-drug conjugate (ADC) (51)
Approvals (7127)
Artificial intelligence (124)
Autoimmune disease (13)
Automation (5)
Bankruptcy (182)
Best Places to Work (5280)
BIOSECURE Act (9)
Biosimilars (59)
Biotechnology (48)
Bladder cancer (24)
Brain cancer (18)
Breast cancer (103)
Cancer (761)
Cardiovascular disease (75)
Career advice (656)
Career pathing (13)
CAR-T (44)
Cell therapy (139)
Cervical cancer (5)
Clinical research (34481)
Collaboration (399)
Compensation (172)
Complete response letters (17)
COVID-19 (948)
CRISPR (22)
C-suite (166)
Cystic fibrosis (51)
Data (776)
Denatured (16)
Depression (11)
Diabetes (114)
Diagnostics (1931)
Digital health (4)
Diversity (2)
Diversity, equity & inclusion (18)
Drug discovery (70)
Drug pricing (69)
Drug shortages (15)
Duchenne muscular dystrophy (49)
Earnings (42864)
Editorial (22)
Employer branding (5)
Employer resources (59)
Events (44507)
Executive appointments (503)
FDA (7604)
Featured Employer (21)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (1)
Funding (313)
Gene editing (47)
Generative AI (9)
Gene therapy (130)
GLP-1 (396)
Government (1672)
Grass and pollen (2)
Guidances (23)
Healthcare (5810)
Huntington's disease (7)
IgA nephropathy (13)
Immunology and inflammation (47)
Indications (12)
Infectious disease (997)
Inflammatory bowel disease (71)
Inflation Reduction Act (6)
Influenza (18)
Intellectual property (61)
Interviews (95)
IPO (7772)
IRA (31)
Job creations (2222)
Job search strategy (595)
Kidney cancer (7)
Labor market (17)
Layoffs (215)
Leadership (5)
Legal (4054)
Liver cancer (22)
Lung cancer (97)
Lymphoma (60)
Machine learning (1)
Management (20)
Manufacturing (187)
MASH (41)
Medical device (3106)
Medtech (3109)
Mergers & acquisitions (11821)
Metabolic disorders (324)
Multiple sclerosis (27)
NASH (15)
Neurodegenerative disease (34)
Neuropsychiatric disorders (9)
Neuroscience (696)
NextGen: Class of 2025 (2245)
Non-profit (941)
Northern California (957)
Now hiring (9)
Obesity (176)
Opinion (144)
Ovarian cancer (30)
Pain (56)
Pancreatic cancer (18)
Parkinson's disease (56)
Partnered (8)
Patents (136)
Patient recruitment (37)
Peanut (13)
People (36349)
Pharmaceutical (66)
Pharmacy benefit managers (12)
Phase I (9395)
Phase II (14817)
Phase III (12724)
Pipeline (569)
Policy (79)
Postmarket research (1478)
Preclinical (3706)
Press Release (35)
Prostate cancer (53)
Psychedelics (13)
Radiopharmaceuticals (147)
Rare diseases (204)
Real estate (2952)
Recruiting (28)
Regulatory (11534)
Reports (19)
Research institute (753)
Resumes & cover letters (90)
Rett syndrome (2)
RNA editing (2)
RSV (9)
Schizophrenia (43)
Series A (61)
Series B (22)
Service/supplier (4)
Sickle cell disease (36)
Southern California (904)
Special edition (9)
Spinal muscular atrophy (86)
Sponsored (12)
Startups (1903)
State (2)
Stomach cancer (4)
Supply chain (41)
Tariffs (21)
The Weekly (34)
United States (9169)
Vaccines (217)
Venture capitalists (20)
Weight loss (121)
Women's health (13)
Worklife (5)
Date
Today (4)
Last 7 days (213)
Last 30 days (1049)
Last 365 days (15005)
2025 (4347)
2024 (15977)
2023 (17948)
2022 (24561)
2021 (25419)
2020 (23939)
2019 (18943)
2018 (14862)
2017 (16484)
2016 (15697)
2015 (18338)
2014 (14695)
2013 (12351)
2012 (13340)
2011 (13882)
2010 (12659)
Location
Africa (366)
Alabama (16)
Alaska (3)
Arizona (82)
Arkansas (5)
Asia (23408)
Australia (3126)
California (2222)
Canada (1115)
China (268)
Colorado (127)
Connecticut (88)
Delaware (63)
Europe (46647)
Florida (382)
Georgia (68)
Idaho (12)
Illinois (228)
India (17)
Indiana (194)
Iowa (1)
Japan (97)
Kansas (60)
Kentucky (13)
Louisiana (1)
Maine (7)
Maryland (375)
Massachusetts (1825)
Michigan (47)
Minnesota (123)
Missouri (29)
Montana (21)
Nebraska (12)
Nevada (18)
New Hampshire (19)
New Jersey (949)
New Mexico (13)
New York (634)
North Carolina (464)
North Dakota (2)
Northern California (957)
Ohio (67)
Oklahoma (7)
Oregon (17)
Pennsylvania (539)
Puerto Rico (10)
Rhode Island (13)
South America (597)
South Carolina (2)
Southern California (904)
Tennessee (42)
Texas (343)
Utah (56)
Virginia (81)
Washington D.C. (35)
Washington State (141)
West Virginia (1)
Wisconsin (15)
322,504 Results for "parnell pharmaceuticals holdings".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Parnell Pharmaceuticals Holdings Ltd Announces Extension of Rights Offering
Parnell Pharmaceuticals Holdings Ltd announced the extension of the backstopped rights offering to raise gross proceeds of approximately US$4.0 million.
January 6, 2023
·
3 min read
Parnell Pharmaceuticals Holdings Ltd Announces Commencement of Rights Offering
Parnell Pharmaceuticals Holdings Ltd commenced its previously announced backstopped rights offering to raise gross proceeds of approximately US$4.0 million.
December 6, 2022
·
4 min read
Deals
Parnell Pharmaceuticals Holdings Ltd Announces Proposed Rights Offering
Parnell Pharmaceuticals Holdings Ltd (OTC Pink ® Open Market: PARNF) (“Parnell”) announced its intention to raise US$4.0 million through a backstopped rights offering at no charge (the “Rights Offering”) for qualifying shareholders of record as of December 6, 2022 (the “Record Date”).
December 1, 2022
·
3 min read
Duchenne muscular dystrophy
Committee Recommends EU Trials of Sarepta’s Elevidys Continue, Day After Holds
One day after the European Medicines Agency requested that three clinical trials of Elevidys be placed on hold after the death of a U.S. teenager, a data monitoring committee concluded that they should continue unchanged.
April 4, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025
February 21, 2025
·
3 min read
Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum
Parnell Pharmaceuticals Holdings Ltd, a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, provides notice of its Annual General Meeting to be held Friday, 15th July 2022 at 8:30 a.m..
June 21, 2022
·
2 min read
Press Releases
Ionis to hold first quarter 2025 financial results webcast
April 16, 2025
·
1 min read
Press Releases
Additional Member for the Board of Directors of Bachem Holding AG
April 3, 2025
·
3 min read
Press Releases
Revvity to Hold Earnings Call on Monday, April 28, 2025
April 3, 2025
·
1 min read
Press Releases
Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canada’s Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for ELYXYB®’s Acute Treatment of Migraine With or Without Aura in Canada
April 16, 2025
·
8 min read
1 of 32,251
Next
